Iopromide

CAS 73334-07-3 4 current records 2 historicalSmall Molecule

Who holds supplier records for Iopromide? 4 organisations hold a current record for Iopromide: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Germany (1) and China (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Iopromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/iopromide

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Iopromide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Germany1China1Country not recorded for 2
  • Bayer AG
    Active DMF 8178 · latest filing Aug 1989
    GermanyCEP Company GMP cert on record
  • ALP PHARM BEIJING CO LTD
    Active DMF 35356 · latest filing Dec 2020
  • SUZHOU RYWAY BIOTECH CO LTD
    Active DMF 42381 · latest filing Aug 2025
  • Zhejiang Starry Pharmaceutical Co., Ltd
    ChinaCEP
Need Iopromide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Iopromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
BAYER AG LeverkusenDE
CEP 2020-273 - Rev 01
Iopromide, 202008
Oct 2025—
ZHEJIANG STARRY PHARMACEUTICAL CO., LTD. XianjuCN
CEP 2022-232 - Rev 01
Iopromide
May 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Iopromide are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • SICHUAN RENAN PHARMACEUTICAL CO LTD
    Inactive DMF 38239 · filed Apr 2023
  • South · Inactive DMF 25680 · filed Jan 2012

Overview

Iopromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1725).

Chemical identity

IUPAC name
1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide
Canonical SMILES
CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I
InChIKey
DGAIEPBNLOQYER-UHFFFAOYSA-N
Synonyms
Iopromida, Iopromide, Proscope, Ultravist, Ultravist 150, Ultravist 240, Ultravist 300, Ultravist 370, Ultravist (pharmacy bulk), ZK 35760, ZK-35760, Iopromidum

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Radiographic Contrast Agent
Mechanism of action
X-Ray Contrast Activity

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Iopromide?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Iopromide: Bayer AG (Germany), ALP PHARM BEIJING CO LTD, SUZHOU RYWAY BIOTECH CO LTD and Zhejiang Starry Pharmaceutical Co., Ltd (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Iopromide Drug Master Files are active?

Bayer AG (DMF 8178), ALP PHARM BEIJING CO LTD (DMF 35356) and SUZHOU RYWAY BIOTECH CO LTD (DMF 42381). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Iopromide records mean?

2 organisations have only inactive Type II DMFs for Iopromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Iopromide have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Iopromide on the EDQM register, including BAYER AG Leverkusen (DE) and ZHEJIANG STARRY PHARMACEUTICAL CO., LTD. Xianju (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Iopromide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Iopromide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.